MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...
In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...
Pittsburgh-based Highmark Health signed an outcomes-based contract with drugmaker AstraZeneca for its asthma and chronic obstructive pulmonary disease drug Symbicort. The contract will apply to ...
LONDON, June 4 (Reuters) - A new version of AstraZeneca Plc's Symbicort asthma drug, which can be used simultaneously as maintenance and reliever therapy, has been launched in Britain, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results